Molecular epidemiology of recently emergent ciprofloxacin-resistant Neisseria gonorrhoeae in South Africa

Sexually Transmitted Diseases

Volumn 33, Issue 6, 2006, Pages 357-360

  Moodley, Prashini ^a   Martin, Iona M C ^b   Pillay, Keshree ^a   Ison, Catherine A ^b   Sturm, A Willem ^a  

^a UNIVERSITY OF KWAZULU NATAL   (South Africa)

^b CENTRAL PUBLIC HEALTH LABORATORY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CEFTRIAXONE; CIPROFLOXACIN; PENICILLIN G; SPECTINOMYCIN; TETRACYCLINE;

ANTIBIOTIC RESISTANCE; ANTIMICROBIAL ACTIVITY; BACTERIUM ISOLATE; CIPROFLOXACIN RESISTANT NEISSERIA GONORRHOEAE; CONFERENCE PAPER; GONOCOCCAL URETHRITIS; GONORRHEA; HUMAN; MALE; MINIMUM INHIBITORY CONCENTRATION; MOLECULAR EPIDEMIOLOGY; MOLECULAR TYPING; NEISSERIA GONORRHOEAE; NEISSERIA GONORRHOEAE MULTIANTIGEN SEQUENCE TYPING; NONHUMAN; SOUTH AFRICA;

ANTI-INFECTIVE AGENTS; CIPROFLOXACIN; DRUG RESISTANCE, BACTERIAL; GONORRHEA; HUMANS; MALE; MICROBIAL SENSITIVITY TESTS; NEISSERIA GONORRHOEAE; SOUTH AFRICA; URETHRITIS;

EID: 33744807176     PISSN: 01485717     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.olq.0000194581.02022.f0     Document Type: Conference Paper

References (20)

1. Cohen MS. HIV and sexually transmitted diseases: lethal synergy. Top HIV Med 2004; 12:104-107.
2. Fleming DT, Wasserheit JN. From epidemiological synergy to public health policy and practice: the contribution of other sexually transmitted diseases to sexual transmission of HIV infection. Sex Transm Infect 1999; 75:3-17.
3. d'Cruz-Grote D. Prevention of HIV infection in developing countries. Lancet 1996; 348:1071-1074.
4. Grosskurth H, Mwijarubi E, Todd J, et al. Operational performance of an STD control programme in Mwanza Region, Tanzania. Sex Transm Infect 2000; 76:426-436.
5. Dallabetta GA, Gerbase AC, Holmes KK. Problems, solutions, and challenges in syndromic management of sexually transmitted diseases. Sex Transm Infect 1998; 74:S1-11.
6. World Health Organization. Guidelines for the management of sexually transmitted infections: 2003. Available at: http://www. who.int/ reproductivehealth/publications/rhr_01_10_mngt_stis/guidelines_mngt_stis.pdf. Accessed March 12, 2006.
7. Catchpole MA. The role of epidemiology and surveillance systems in the control of sexually transmitted diseases. Genitourin Med 1996; 72:321-329.
8. Moodley P, Pillay C, Goga R, Kharsany ABM, Sturm AW. Evolution in the trends of antimicrobial resistance in Neisseria gonorrhoeae isolated in Durban over a 5 year period: impact of the introduction of syndromic management. J Antimicrob Chemother 2001; 48:853-859.
9. Moodley P, Sturm AW. Ciprofloxacin resistance in Neisseria gonorrhoeae. Lancet 2001; 357:1295-1296.
10. Moodley P, Moodley D, Sturm AW. Ciprofloxacin resistant Neisseria gonorrhoeae in South Africa. Int J Antimicrob Agents 2004; 24:192-193.
11. th ed. Villanova, PA: National Committee for Clinical Laboratory Standards, 1997. Approved standard M7-A4.
12. Martin IMC, Ison CA, Aanensen DA, Fenton KA, Spratt BG. Rapid sequence-based identification of gonococcal clusters in a large metropolitan area. J Infect Dis 2004; 189:1497-1505.
13. NG-MAST [database online]. Available at: http://www.ng-mast.net. 2004.
14. Thompson JD, Gibson TJ, Plewniak F, Jeanmougin F, Higgins DG. The ClustalX Windows interface: flexible strategies for multiple sequence alignment aided by quality analysis tools. Nucleic Acids Res 1997; 24:4876-4882.
15. Adler MW. Sexually transmitted disease control in developing countries. Genitourin Med 1996; 72:83-88.
16. Australian Gonococcal Surveillance Programme. Annual report of the Australian Gonococcal Surveillance Programme, 2002. Commun Dis Intell 2003; 27:1289-1295.
17. Ray K, Bala M, Kumari S, Narain JP. Antimicrobial resistance of Neisseria gonorrhoeae in selected World Health Organization Southeast Asia Region countries: an overview. Sex Transm Dis 2005; 32:178-184.
18. Ito M, Yasuda M, Yokoi S, et al. Remarkable increase in central Japan in 2001-2002 of Neisseria gonorrhoeae isolates with decreased susceptibility to penicillin, tetracycline, oral cephalosporins, and fluoroquinolones. Antimicrob Agents Chemother 2004; 48:3185-3187.
19. Thornsberry C, Jaffee H, Brown ST, Edwards T, Biddle JW, Thompson SE. Spectinomycin-resistant Neisseria gonorrhoeae. JAMA 1977; 22:2405-2406.
20. Moodley P, Martin IMC, Ison CA, Sturm AW. Typing of Neisseria gonorrhoeae reveals rapid reinfection in rural South Africa. J Clin Microbiol 2002; 40:4567-4570.